ALX Oncology Grants 500,000 Inducement Stock Options to New GC

ALX Oncology Holdings Inc. granted an inducement stock option to Michael Listgarten, its new General Counsel, to purchase 500,000 shares of common stock. The grant, made on June 29, 2026, has an exercise price of $2.20 per share, matching the closing price on the grant date. The option vests 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter, contingent on continued employment.